HEC74647

Sunshine Lake Pharma Co., Ltd. · Phase 1 active Small molecule

At a glance

Generic name	HEC74647
Sponsor	Sunshine Lake Pharma Co., Ltd.
Modality	Small molecule
Phase	Phase 1

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pharmacokinetics of Midazolam When Co-administered With HEC74647 and HEC110114 (PHASE1)
Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects (PHASE1)
The Tolerability, Pharmacokinetics and Pharmacodynamics Study of HEC74647 in HCV-infected Subjects (PHASE1)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

HEC74647 CI brief — competitive landscape report
HEC74647 updates RSS · CI watch RSS
Sunshine Lake Pharma Co., Ltd. portfolio CI